BAT raises growth target for smokeless products
- On Tuesday, British American Tobacco raised its growth forecast for smokeless products to mid-teens, citing improved demand in the United States following a significant policy shift.
- The Food and Drug Administration said last month it would use 'enforcement discretion' for unauthorized products, allowing BAT to prepare its Modern Oral and Vapour portfolio for the United States market.
- BAT reaffirmed its 2026 guidance for 3% to 5% revenue growth, while global cigarette industry sales volumes are expected to fall by around 2.5%, a steeper decline than previously forecast.
- CEO Tadeu Marroco said the company aims to be a 'predominately smokeless' business by 2035, calling the FDA's guidance an 'important step toward effective enforcement and expanding market access.'
- Richard Hunter, Head of Markets at interactive investor, noted the industry faces regulatory censure and ethical concerns, yet BAT balances these hurdles with robust profitability from tobacco products.
14 Articles
14 Articles
BAT raises growth target for smokeless products
British American Tobacco has today raised its forecast for revenue from smoking alternatives like vapes, partly thanks to strong demand in the US, where the company is preparing to launch new products after a significant policy shift.
British American Tobacco raises growth expectations for smokeless products, Velo and Vuse driving business transformation
According to the Belfast Telegraph, British American Tobacco (BAT) has raised its growth expectations for the e-cigarette business, indicating that global consumers are increasingly shifting from traditional cigarettes to alternative products such as e-cigarettes and nicotine pouches. BAT stated that the sales of the new category (New Category) of products, including e-cigarettes, nicotine pouches and other new types of tobacco products, are exp…
BAT Bets Big on Vapes After US Policy Shift, but Investors Send Shares Tumbling 4%
BAT raised its forecast for revenue from vapes and nicotine pouches.Shares fell 4 per cent after the company left overall guidance unchanged.A recent US regulatory shift is expected to open up new opportunities for nicotine products.British American Tobacco (BAT) has raised its growth expectations for vaping and other nicotine alternatives after a regulatory shift in the US, although investors appeared unconvinced after the company kept its wide…
Coverage Details
Bias Distribution
- 56% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium
